Tags

Type your tag names separated by a space and hit enter

The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients.
J Wound Care 2012; 21(2):78, 80, 82-85JW

Abstract

OBJECTIVE

To summarise our experience of the use of medicinal maggots for the debridement of necrotic chronic wounds and to try and identify prognostic factors for debridement success and associated pain.

METHOD

During the years 1996–2009, 723 wounds of 435 patients (180 females and 255 males) were treated with maggot debridement therapy (MDT) in 16 departments and units of the Hadassah Hospital in Jerusalem, Israel. Overall, 261 patients were treated during hospitalisation, while 174 were treated as ambulatory patients. In 90.5% of the patients the wounds were located on the leg, but only 48.0% had diabetic foot ulcers. The wound duration range from one to 240 months (mean=8.9; median=4 months). Sterile maggots of the green bottle fly, Lucilia sericata, were used for MDT. In 90.6% of the cases, maggots were placed directly on the wound using a cage-like dressing and left for 24 hours, while in 9.4% of the patients maggots concealed in a tea-bag like polyvinyl netting were used. The concealed maggots were left on the wound for 2–3 days.

RESULTS

The number of treatments was 1–48 (mean=2.98; median=2) and the duration of the treatment varied between one and 81 days (mean=4.65; median=3). In 357 patients (82.1%) complete debridement of the wound was achieved, while in 73 patients (16.8%) the debridement was partial and in five (1.1%) it was ineffective. Increased pain or discomfort during MDT were reported in 38% of the patients.

CONCLUSION

MDT is a very safe, simple and effective treatment modality for chronic wounds in ambulatory and hospitalised patients.

DECLARATION OF INTEREST

There were no external sources of funding for this study. The authors have no additional conflicts of interest to declare.

Authors+Show Affiliations

Department of Dermatology and Venereology, Haddasah University Hospital, Jerusalem, Israel.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

22584527

Citation

Gilead, L, et al. "The Use of Maggot Debridement Therapy in the Treatment of Chronic Wounds in Hospitalised and Ambulatory Patients." Journal of Wound Care, vol. 21, no. 2, 2012, pp. 78, 80, 82-85.
Gilead L, Mumcuoglu KY, Ingber A. The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients. J Wound Care. 2012;21(2):78, 80, 82-85.
Gilead, L., Mumcuoglu, K. Y., & Ingber, A. (2012). The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients. Journal of Wound Care, 21(2), pp. 78, 80, 82-85.
Gilead L, Mumcuoglu KY, Ingber A. The Use of Maggot Debridement Therapy in the Treatment of Chronic Wounds in Hospitalised and Ambulatory Patients. J Wound Care. 2012;21(2):78, 80, 82-85. PubMed PMID: 22584527.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The use of maggot debridement therapy in the treatment of chronic wounds in hospitalised and ambulatory patients. AU - Gilead,L, AU - Mumcuoglu,K Y, AU - Ingber,A, PY - 2012/5/16/entrez PY - 2012/5/16/pubmed PY - 2012/6/15/medline SP - 78, 80, 82-85 JF - Journal of wound care JO - J Wound Care VL - 21 IS - 2 N2 - OBJECTIVE: To summarise our experience of the use of medicinal maggots for the debridement of necrotic chronic wounds and to try and identify prognostic factors for debridement success and associated pain. METHOD: During the years 1996–2009, 723 wounds of 435 patients (180 females and 255 males) were treated with maggot debridement therapy (MDT) in 16 departments and units of the Hadassah Hospital in Jerusalem, Israel. Overall, 261 patients were treated during hospitalisation, while 174 were treated as ambulatory patients. In 90.5% of the patients the wounds were located on the leg, but only 48.0% had diabetic foot ulcers. The wound duration range from one to 240 months (mean=8.9; median=4 months). Sterile maggots of the green bottle fly, Lucilia sericata, were used for MDT. In 90.6% of the cases, maggots were placed directly on the wound using a cage-like dressing and left for 24 hours, while in 9.4% of the patients maggots concealed in a tea-bag like polyvinyl netting were used. The concealed maggots were left on the wound for 2–3 days. RESULTS: The number of treatments was 1–48 (mean=2.98; median=2) and the duration of the treatment varied between one and 81 days (mean=4.65; median=3). In 357 patients (82.1%) complete debridement of the wound was achieved, while in 73 patients (16.8%) the debridement was partial and in five (1.1%) it was ineffective. Increased pain or discomfort during MDT were reported in 38% of the patients. CONCLUSION: MDT is a very safe, simple and effective treatment modality for chronic wounds in ambulatory and hospitalised patients. DECLARATION OF INTEREST: There were no external sources of funding for this study. The authors have no additional conflicts of interest to declare. SN - 0969-0700 UR - https://www.unboundmedicine.com/medline/citation/22584527/The_use_of_maggot_debridement_therapy_in_the_treatment_of_chronic_wounds_in_hospitalised_and_ambulatory_patients_ L2 - http://www.magonlinelibrary.com/doi/full/10.12968/jowc.2012.21.2.78?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -